M T Madon Exports

M T Madon Exports, established on August 30, 1997, is a proprietary firm based in Mumbai, Maharashtra, India. The company specializes in the export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Over the years, it has built a reputation for delivering quality pharmaceutical products to various international markets. The firm's registered office is located at 23, Pinjari Street, 346 A.R. Street, Crawford Market, Mumbai 400003, India.

As of March 2026, M T Madon Exports operates as a small enterprise under the MSME classification for the financial year 2024-25. The company is registered under the Goods and Services Tax (GST) with the number 27AABFM1239Q1ZZ, indicating its active status and compliance with Indian tax regulations.

Specific details regarding M T Madon Exports' manufacturing facilities are not publicly disclosed. The company primarily focuses on the export of finished pharmaceutical formulations, suggesting that it may source products from various manufacturers rather than producing them in-house. This approach allows the firm to offer a diverse range of products without the complexities associated with manufacturing operations.

The principal executive and proprietor of M T Madon Exports is Mr. Kamlesh P. Shah. His leadership has been instrumental in steering the company towards its current position in the pharmaceutical export sector. Under his guidance, the firm has established a strong presence in international markets, particularly in regions such as Africa and Southeast Asia.

M T Madon Exports has demonstrated a consistent presence in regulated markets, particularly in Africa. The company has engaged in multiple shipments to countries like Kenya, exporting pharmaceutical products such as Pantocid IV 40mg Injection. These transactions indicate the company's adherence to international standards and its ability to navigate the regulatory landscapes of these markets.

M T Madon Exports has made significant inroads into emerging markets, notably in Africa and Southeast Asia. The company's export activities in these regions underscore its commitment to expanding its global footprint and meeting the pharmaceutical needs of developing economies. By leveraging the World Health Organization's prequalification program, M T Madon Exports ensures that its products meet international quality standards, facilitating smoother market access in these regions.

M T Madon Exports' geographic strategy appears to be focused on diversification, with a notable emphasis on emerging markets in Africa and Southeast Asia. This approach mitigates concentration risk and positions the company to capitalize on growth opportunities in regions with increasing demand for pharmaceutical products. The strategic direction suggests a long-term commitment to global expansion and market penetration.

Specific information regarding M T Madon Exports' interactions with the U.S. Food and Drug Administration (FDA), including facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history, is not publicly available. This lack of transparency may indicate limited or no direct engagement with the U.S. market.

There is no publicly available information confirming that M T Madon Exports holds World Health Organization (WHO) prequalification or European Union Good Manufacturing Practice (EU GMP) certificates. The absence of such certifications may impact the company's ability to access certain international markets that require these standards.

M T Madon Exports operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company holds the necessary manufacturing licenses and approvals from state drug controllers, ensuring compliance with Indian pharmaceutical regulations. Additionally, M T Madon Exports possesses the required export No Objection Certificates (NOCs), facilitating its international trade activities.

As of March 2026, there are no publicly available records indicating any Form 483 observations, warning letters, or import alerts issued against M T Madon Exports. This suggests that the company maintains a clean regulatory record, reflecting its commitment to adhering to industry standards and regulations.

M T Madon Exports operates in a competitive landscape with several key players in the pharmaceutical export sector. While specific market share data is not publicly available, the company's focus on emerging markets in Africa and Southeast Asia positions it to compete effectively by offering quality products tailored to the needs of these regions. The firm's ability to navigate diverse regulatory environments and establish partnerships with local distributors enhances its competitive edge.

M T Madon Exports' key differentiators include its strategic focus on emerging markets, particularly in Africa and Southeast Asia, and its ability to offer a diverse range of pharmaceutical products. The company's commitment to quality and compliance with international standards, as evidenced by its export activities, further distinguishes it in the marketplace.

M T Madon Exports' current strategic direction emphasizes expansion into emerging markets, leveraging its expertise in pharmaceutical exports to meet the growing demand in these regions. The company's future outlook appears positive, with opportunities to enhance its product portfolio and strengthen its market presence through strategic partnerships and adherence to international quality standards.

M T Madon Exports has demonstrated a consistent track record in exporting pharmaceutical products, with a total export value of $76,000 USD across 53 shipments. The company's reliability is further evidenced by its ongoing partnerships with international buyers, indicating a stable and dependable supply chain. The firm's focus on quality and compliance with international standards enhances its reputation as a trustworthy supplier.

Importers should verify the following certifications when considering M T Madon Exports as a supplier:

• FDA Registration: Confirm the company's registration status with the U.S. Food and Drug Administration to ensure compliance with U.S. regulations.

• WHO Prequalification: Verify if the company's products are prequalified by the World Health Organization, indicating adherence to international quality standards.

• EU GMP Certification: Check for certification under European Union Good Manufacturing Practice, ensuring product quality and safety.

• ISO Certification: Assess whether the company holds relevant ISO certifications, reflecting its commitment to quality management systems.

These certifications can typically be verified through the respective regulatory bodies' official websites or by requesting documentation directly from the supplier.

When conducting due diligence on M T Madon Exports, consider the following steps:

• Verify Regulatory Compliance: Ensure the company holds necessary licenses and certifications from relevant authorities, such as CDSCO in India.

• Assess Product Quality: Request samples and review quality control processes to confirm adherence to international standards.

• Evaluate Financial Stability: Review financial statements and credit history to assess the company's financial health.

• Check References: Contact previous and current clients to gauge satisfaction and reliability.

• Inspect Supply Chain Practices: Evaluate the company's supply chain for transparency and ethical practices.

Red flags to watch for include a lack of verifiable certifications, inconsistent product quality, financial instability, and negative feedback from business partners.

Recommended pre-order checks involve confirming product availability, lead times, shipping terms, and after-sales support to ensure a smooth transaction process.